CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $28,450,000 | -59.5% | 1,913,234 | -32.4% | 0.44% | -59.5% |
| Q1 2019 | $70,298,000 | +42.2% | 2,832,300 | +2.9% | 1.09% | +19.0% |
| Q4 2018 | $49,430,000 | -24.7% | 2,752,200 | +23.2% | 0.91% | +15.7% |
| Q3 2018 | $65,629,000 | -40.6% | 2,234,570 | -8.1% | 0.79% | -40.1% |
| Q2 2018 | $110,532,000 | -12.6% | 2,430,870 | +1.5% | 1.32% | -16.0% |
| Q1 2018 | $126,502,000 | -5.6% | 2,395,870 | +21.5% | 1.57% | -7.5% |
| Q4 2017 | $134,074,000 | -31.9% | 1,971,670 | -17.5% | 1.70% | -9.8% |
| Q3 2017 | $196,826,000 | -0.1% | 2,388,670 | +13.5% | 1.88% | -8.9% |
| Q2 2017 | $197,032,000 | +1452.8% | 2,104,370 | +218.4% | 2.06% | +1441.0% |
| Q1 2016 | $12,689,000 | -50.3% | 660,900 | -9.4% | 0.13% | -42.0% |
| Q4 2015 | $25,536,000 | -74.9% | 729,600 | -34.0% | 0.23% | -77.5% |
| Q3 2015 | $101,699,000 | +15.1% | 1,105,900 | +10.0% | 1.03% | +58.5% |
| Q2 2015 | $88,337,000 | +19.0% | 1,005,200 | +0.5% | 0.65% | +2.2% |
| Q1 2015 | $74,260,000 | +85.7% | 1,000,400 | +40.1% | 0.63% | +66.0% |
| Q4 2014 | $39,990,000 | – | 714,100 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |